Ropinirole hydrochloride for amyotrophic lateral sclerosis: A single-center, randomized feasibility, double-blind, placebo-controlled trial

Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, Yugaku Daté, Kensuke Okada, Chai Muh Chyi, Ayumi Nishiyama, Naoki Suzuki, Koki Fujimori, Masaki Takao, Miwa Hirai, Yasuaki Kabe, Makoto Suematsu, Masahiro Jinzaki, Masashi Aoki, Yuto Fujiki, Yasunori Sato, Norihiro Suzuki, Jin Nakahara, Hideyuki Okano
doi: https://doi.org/10.1101/2021.12.05.21267266

Article Information

doi 
https://doi.org/10.1101/2021.12.05.21267266
History 
  • December 7, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Satoru Morimoto, M.D.1,2,*,
  2. Shinichi Takahashi, M.D.1,2,3,*,
  3. Daisuke Ito, M.D.2,
  4. Yugaku Daté, M.D.2,
  5. Kensuke Okada, M.D.2,
  6. Chai Muh Chyi, Ph.D.1,4,
  7. Ayumi Nishiyama, M.D.5,
  8. Naoki Suzuki, M.D.5,
  9. Koki Fujimori, Ph.D.1,
  10. Masaki Takao, M.D.6,
  11. Miwa Hirai7,
  12. Yasuaki Kabe, Ph.D.7,
  13. Makoto Suematsu, M.D.7,
  14. Masahiro Jinzaki, M.D.8,
  15. Masashi Aoki, M.D.5,
  16. Yuto Fujiki9,
  17. Yasunori Sato, Ph.D.10,
  18. Norihiro Suzuki, M.D.2,
  19. Jin Nakahara, M.D.2 and
  20. Hideyuki Okano, M.D.1,†
  1. 1Department of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan
  2. 2Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan
  3. 3Department of Neurology and Stroke, Saitama Medical University International Medical Center, Saitama, 350-1298, Japan
  4. 4Keio University Global Research Institute, Tokyo, 108-8345, Japan
  5. 5Department of Neurology, Tohoku University Graduate School of Medicine, Miyagi, 980-8575, Japan
  6. 6Department of Clinical Laboratory, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-0031, Japan
  7. 7Department of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan
  8. 8Department of Radiology, Keio University School of Medicine, Tokyo, 160-8582, Japan
  9. 9Keio University Hospital Clinical and Translational Research Center, Tokyo, 160-8582, Japan
  10. 10Department of Preventive Medicine and Public Health, Keio University School of Medicine, 160-8582, Japan
  1. ↵†Correspondence: Hideyuki Okano, MD, PhD, Dean, Keio University Graduate School of Medicine, Professor, Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan, Tel: +81-3-5363-3747, Fax: +81-3-3357-5445, email: hidokano{at}keio.jp
Back to top
Posted December 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Ropinirole hydrochloride for amyotrophic lateral sclerosis: A single-center, randomized feasibility, double-blind, placebo-controlled trial
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, Yugaku Daté, Kensuke Okada, Chai Muh Chyi, Ayumi Nishiyama, Naoki Suzuki, Koki Fujimori, Masaki Takao, Miwa Hirai, Yasuaki Kabe, Makoto Suematsu, Masahiro Jinzaki, Masashi Aoki, Yuto Fujiki, Yasunori Sato, Norihiro Suzuki, Jin Nakahara, Hideyuki Okano
medRxiv 2021.12.05.21267266; doi: https://doi.org/10.1101/2021.12.05.21267266
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area